Skip to main content

Intense-Pulsed Light (IPL) for Telengiectasia and Reticular Veins

  • Chapter
  • First Online:
Aesthetic Applications of Intense Pulsed Light

Abstract

The use of Intense Pulsed Light (IPL) therapy in the treatment of a variety of dermatologic conditions has increased in use since the early 1990’s. In particular, it has become more popular in the treatment of disorders of chronic venous insufficiency, including reticular veins and telangiectasias. In the past, sclerotherapy and traditional lasers had been used for this purpose, however these procedures may leave patients with adverse long-term effects. The IPL source emits light from a wide spectrum of wavelengths but use of selective cut-off filters allows safe and effective treatment according to an individual’s skin type. This helps reduce adverse effects such as blistering, erythema, and burns that are commonly seen when traditional therapy is used. When proper patient selection and methodology is implemented, IPL has proven to be a successful alternative to traditional therapies and has been very effective, specifically for their use in treatment of facial telangiectasias. Further studies need to be done to elucidate their effects in the treatment of reticular veins alone, however the few studies that have been done are promising.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ruckley C, Evans C, Allan P, Lee A, Fowkes F. Telangiectasia in the Edinburgh vein study: epidemiology and association with trunk varices and symptoms. Eur J Vasc Endovasc Surg. 2008;36:719–24.

    Article  CAS  Google Scholar 

  2. Nakano LC, Cacione DG, Baptista-Silva JC, Flumignan RL. Treatment for telangiectasias and reticular veins. Cochrane Database Syst Rev. 2017;2017:CD012723. https://doi.org/10.1002/14651858.CD012723.

    Article  PubMed Central  Google Scholar 

  3. Hercogova J, Brazzini B, Hautmann G, Ghersetich I, Lotti T. Laser treatment of cutaneous vascular lesions: face and leg telangiectases. J Eur Acad Dermatol Venereol. 2002;16:12–8.

    Article  CAS  Google Scholar 

  4. Porter JM, Moneta GL, on Chronic AICC, Disease V. Reporting standards in venous disease: an update. J Vasc Surg. 1995;21:635–45.

    Article  CAS  Google Scholar 

  5. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005;15:175–84.

    Article  Google Scholar 

  6. Engel A, Johnson M-L, Haynes SG. Health effects of sunlight exposure in the United States: results from the first National Health and nutrition examination survey, 1971-1974. Arch Dermatol. 1988;124:72–9.

    Article  CAS  Google Scholar 

  7. Callam M. Epidemiology of varicose veins. Br J Surg. 1994;81:167–73.

    Article  CAS  Google Scholar 

  8. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40:1248–52.

    Article  Google Scholar 

  9. Green D. Reticular veins, incompetent reticular veins, and their relationship to telangiectases. Dermatol Surg. 1998;24:1129–41.

    CAS  PubMed  Google Scholar 

  10. Weiss RA, Weiss MA. Doppler ultrasound findings in reticular veins of the thigh subdermic lateral venous system and implications for sclerotherapy. J Dermatol Surg Oncol. 1993;19:947–51.

    Article  CAS  Google Scholar 

  11. Somjen GM, Ziegenbein R, Johnston AH, Royle JP. Anatomical examination of leg telangiectases with duplex scanning. J Dermatol Surg Oncol. 1993;19:940–5.

    Article  CAS  Google Scholar 

  12. Astner S, Anderson RR. Treating vascular lesions. Dermatol Ther. 2005;18:267–81.

    Article  Google Scholar 

  13. Kauvar AN, Lou WW. Pulsed alexandrite laser for the treatment of leg telangiectasia and reticular veins. Arch Dermatol. 2000;136:1371–5.

    CAS  PubMed  Google Scholar 

  14. West TB, Alster TS. Comparison of the long-pulse dye (590–595 nm) and KTP (532 nm) lasers in the treatment of facial and leg telangiectasias. Dermatol Surg. 1998;24:221–6.

    CAS  PubMed  Google Scholar 

  15. Babilas P, Schreml S, Szeimies RM, Landthaler M. Intense pulsed light (IPL): a review. Lasers Surg Med. 2010;42:93–104.

    Article  Google Scholar 

  16. DiBernardo BE, Pozner JN. Intense pulsed light therapy for skin rejuvenation. Clin Plast Surg. 2016;43:535–40.

    Article  Google Scholar 

  17. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–71.

    Article  CAS  Google Scholar 

  18. Goldman MP, Eckhouse S, ESC MEDICAL SYSTEMS LPVCSG. Photothermal sclerosis of leg veins. Dermatol Surg. 1996;22:323–30.

    CAS  PubMed  Google Scholar 

  19. Raulin C, Hellwig S, Schönermark MP. Treatment of a nonresponding port-wine stain with a new pulsed light source (PhotoDerm® VL). Lasers Surg Med. 1997;21:203–8.

    Article  CAS  Google Scholar 

  20. Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cutan Laser Ther. 2001;3:169–73.

    Article  CAS  Google Scholar 

  21. Retamar R, Chames C, Pellerano G. Treatment of linear and spider telangiectasia with an intense pulsed light source. J Cosmet Dermatol. 2004;3:187–90.

    Article  CAS  Google Scholar 

  22. Clementoni MT, Gilardino P, Muti GF, Signorini M, Pistorale A, Morselli PG, et al. Intense pulsed light treatment of 1,000 consecutive patients with facial vascular marks. Aesthet Plast Surg. 2006;30:226–32.

    Article  Google Scholar 

  23. Clementoni MT, Gilardino P, Muti GF, Signorini M, Pistorale A, Morselli PG, et al. Facial teleangectasias: our experience in treatment with IPL. Lasers Surg Med. 2005;37:9–13.

    Article  Google Scholar 

  24. Tanghetti EA. Split-face randomized treatment of facial telangiectasia comparing pulsed dye laser and an intense pulsed light handpiece. Lasers Surg Med. 2012;44:97–102.

    Article  Google Scholar 

  25. Fodor L, Ramon Y, Fodor A, Carmi N, Peled IJ, Ullmann Y. A side-by-side prospective study of intense pulsed light and Nd: YAG laser treatment for vascular lesions. Ann Plast Surg. 2006;56:164–70.

    Article  CAS  Google Scholar 

  26. Sadick NS. A dual wavelength approach for laser/intense pulsed light source treatment of lower extremity veins. J Am Acad Dermatol. 2002;46:66–72.

    Article  Google Scholar 

  27. Colaiuda S, Colaiuda F, Gasparotti M. Treatment of deep underlying reticular veins by Nd: Yag laser and IPL source. Minerva Cardioangiol. 2000;48:329–34.

    CAS  PubMed  Google Scholar 

  28. Nymann P, Hedelund L, Hædersdal M. Intense pulsed light vs. long-pulsed dye laser treatment of telangiectasia after radiotherapy for breast cancer: a randomized split-lesion trial of two different treatments. Br J Dermatol. 2009;160:1237–41.

    Article  CAS  Google Scholar 

  29. Murray A, Moore T, Richards H, Ennis H, Griffiths C, Herrick A. Pilot study of intense pulsed light for the treatment of systemic sclerosis-related telangiectases. Br J Dermatol. 2012;167:563–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neil Sadick .

Editor information

Editors and Affiliations

Multiple Choice Questions

Multiple Choice Questions

12.1.1 Q1: True or False, IPL Is Safer and More Efficacious in Facial Versus Leg Veins

  1. (a)

    True

  2. (b)

    False

12.1.2 Q2: The Type of Light IPL Produces Is

  1. (a)

    Noncoherent, polychromatic light

  2. (b)

    Coherent, polychromatic light

  3. (c)

    Noncoherent, monochromatic light

  4. (d)

    Coherent, monochromatic light

12.1.3 Q3: True or False, Reticular Veins and Telangiectasias Are a Symptom of Chronic Venous Insufficiency

  1. (a)

    True

  2. (b)

    False

12.1.4 Q4: IPL and Lasers for Leg Telangiectasias/Reticular Veins Are an Alternative to

  1. (a)

    Endovenous laser ablation

  2. (b)

    Sclerotherapy

  3. (c)

    Endovenous radiofrequency ablation

  4. (d)

    All of the above

12.1.5 Q5: True or False, Telangiectasias and Reticular Veins Always Coexist

  1. (a)

    True

  2. (b)

    False

12.1.6 Q6: What Is the Preferred Wavelength for Treating a Leg Telangiectasias/Reticular Veins

  1. (a)

    1200 nm

  2. (b)

    755 nm

  3. (c)

    580 nm

  4. (d)

    860 nm

12.1.7 Q7: Common Adverse Events Associated with IPL Include

  1. (a)

    Burns

  2. (b)

    Blisters

  3. (c)

    Discoloration

  4. (d)

    All of the above

12.1.8 Q8: True or False, IPL Is Safe for All Skin Types

  1. (a)

    True

  2. (b)

    False

12.1.9 Q9: True or False, IPL Can Be Combined with Lasers and/or Sclerotherapy

  1. (a)

    True

  2. (b)

    False

12.1.10 Q10: When Treating a Patient with IPL, the Ideal Treatment Interval Is:

  1. (a)

    Twice a week

  2. (b)

    Once a month

  3. (c)

    As needed

  4. (d)

    Annually

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Golpanian, R.S., Dorizas, A., Sadick, N. (2020). Intense-Pulsed Light (IPL) for Telengiectasia and Reticular Veins. In: Fodor, L., Ullmann, Y. (eds) Aesthetic Applications of Intense Pulsed Light. Springer, Cham. https://doi.org/10.1007/978-3-030-22829-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-22829-3_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-22828-6

  • Online ISBN: 978-3-030-22829-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics